Nektar TherapeuticsNKTRNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank43
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Percentile
P43
Within normal range
vs 5Y Ago
-9.7x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-12.10%
202460.17%
202326.16%
202231.21%
2021-14.92%
20201.24%
2019-166.67%
2018709.68%
201743.64%
2016-80.33%